Twelfth EDCTP Forum

15–20 Jun 2025 | Kigali, Rwanda

Scandinavian Biopharma

Private company

scandinavianbiopharma.se/Solna, Sweden
1 profile visit

About

We are a research-based specialty biopharma company determined to give people all over the world a longer and better life.

We are currently preparing the start of pivotal phase III trials and expect to the first vaccine preventing diarrhoea caused by ETEC in both endemic populations and travellers.

We distribute a wide range of specialty biopharma products with focus on vaccines and immunoglobulins.

Area of Activities

Biotechnology company

Representatives

Björn Sjöstrand

CEO

Scandinavian Biopharma

Marketplace (1)

  • Project cooperation

    ETVAX prevention of MSD

    A vaccine against ETEC for both children in LMIC and travellers. SBH is currently preparing for the start of pivotal phase III trial

    Author

    Björn Sjöstrand

    CEO at Scandinavian Biopharma

    Stockholm, Sweden